Jonny Kim, a Harvard Medical School graduate and former Navy SEAL, has been selected to join NASA’s next astronaut class.
Sarah Wakeman, an addiction specialist at Massachusetts General Hospital, discusses the role of fentanyl in the country’s opioid crisis.
Two interventions that link clinical care with community resources helped improve key health measures in overweight or obese children at the outset of a study, as reported in JAMA Pediatrics.
New research is following clues that the protein implicated in Alzheimer’s disease is actually an infection fighter, and that the brain plaques that lead to Alzheimer’s-related dementia are, in many cases, a response to infection.
Scientists studying stem cell and regenerative biology are probing the secrets of aging, examining both whether decline is inevitable and how to fight the diseases that multiply with time.
New findings indicate that a smartphone-based semen analyzer can identify abnormal semen samples based on sperm concentration and motility criteria with approximately 98 percent accuracy.
Psychiatrist Jeff Huff is leading an MGH effort to determine whether positive thinking can promote better health.
Researchers find vitamin D helps the body fight acute respiratory infection.
Harvard Medical School scientists and colleagues from Massachusetts General Hospital have partly restored hearing in mice with a genetic form of deafness. The new approach overcomes a longstanding barrier to gene therapy for inherited and acquired deafness.
Harvard researchers at Massachusetts General Hospital have found a topical chemotherapy and an immune-system-activating compound that is able to rapidly clear actinic keratosis lesions from patients participating in a clinical trial.
Harvard Medical School geneticist Stephen Elledge won the 2017 Breakthrough Prize for unraveling the mechanism by which cells sense DNA damage and initiate self-repair.
Startup Magenta Therapeutics licenses technologies from Harvard, Massachusetts General Hospital, and Boston Children’s Hospital that could help transform treatment.
Siyani Chambers was looking forward to finishing his senior year as starting point guard for the men’s basketball team until an injury took him off the court and off campus for a year. Now he’s back.
A new drug compound developed by researchers at Massachusetts General Hospital and the Harvard Stem Cell Institute to treat acute myeloid leukemia is gentle enough to use with patients too frail to endure chemotherapy.
With a wide array of events at the intersection of science, technology, arts, and ethics, HUBweek returns to Boston for a second year. Harvard, one of HUBweek’s founders, will host 14 of the 115 events.
The identification of a molecular compound that combats Huntington’s disease by means of two separate mechanisms may be the watershed moment in the battle against neurodegenerative diseases.
Harvard neurosurgeon Ann-Christine Duhaime thinks a better understanding of the brain’s reward system might help encourage greener living.
Husband and wife Eric Minikel and Sonia Vallabh have found a home at the Broad Institute to work toward a treatment for her fatal disease.
Massachusetts General Hospital researchers are working on a topical treatment that may be available for those with seborrheic keratosis (SK), or liver spots. SKs vary in color from tan to black, can be flat or raised, and range in size from quite small to an inch or more across.
Scientists identify a molecular key that helps cells maintain identity and prevents the conversion of adult cells into induced pluripotent stem cells — a process that would require a cell to “forget” its identity before assuming a new one.
Harvard psychiatrist Ronald Schouten answers questions on the San Bernardino attack and the psychology behind both terrorism and the fear it spreads.
Specialists in addiction see promise in a more comprehensive approach to treating opioid abuse, aided by medication.
Relaxation-response techniques, such as meditation, yoga, and prayer, could reduce the need for health care services by 43 percent, according to a Harvard-affiliated Massachusetts General Hospital study that looked at participants in a relaxation-response-focused training program.
A report on the science of getting hooked on heroin, one in a three-part series examining addiction and new ideas for combatting it.
As one of four sponsors, Harvard will be a major player in HUBweek, hosting 18 presentations celebrating Boston area innovation.
Harvard researchers have found a gene therapy that delivers a protein that suppresses the development of female reproductive organs. This new treatment could improve the survival of patients with ovarian cancer that has recurred after chemotherapy. Recurrence happens 70 percent of the time and is invariably fatal.
Treatment with inhaled nitric oxide (NO) has proved to be lifesaving in newborns, children, and adults with several dangerous conditions. But the availability of the treatment has been limited by the size, weight, and complexity of equipment needed to administer the gas, and the therapy’s high price — until now.
A new test can accurately diagnose the Ebola virus disease within minutes at the point of care.
Afamefuna Nduaguba, a Nigerian immigrant, overcame early struggles at Roxbury Community College to gain a bachelor’s degree from the University of Massachusetts, Boston, and now an M.D. from Harvard Medical School.
Lara Phillips, a Harvard Medical School instructor in emergency medicine, was in Nepal during the April 25 earthquake that devastated Kathmandu and other areas. She and colleagues have traveled from the high-mountain clinic where they worked to offer assistance.
Renee Salas, a Wilderness Medicine Fellow from Harvard-affiliated Massachusetts General Hospital and Harvard Medical School instructor in emergency medicine, was working at a remote clinic near the Mount Everest Base Camp when Saturday’s earthquake struck Nepal. She shared her experience with the Gazette.
With Nepal struggling to grasp the enormous calamity caused by the magnitude 7.8 earthquake that struck north of Kathmandu Saturday, Harvard is mobilizing to help with technical and medical assistance and reaching out to faculty, staff, and students visiting the region.
Harvard Stem Cell Institute researchers at Massachusetts General Hospital have developed an “imageable” mouse model of brain-metastatic breast cancer and shown the potential of a stem-cell-based therapy to eliminate metastatic cells from the brain and prolong survival. The study, published online in the journal Brain, also describes a strategy for preventing the potential negative consequences of stem cell therapy.
New research from Harvard and MIT shows that different cognitive skills peak at different times in lifespan.
Harvard Medical School and Massachusetts General Hospital Professor Emery N. Brown, who also holds appointments at the Massachusetts Institute of Technology, was named to the National Academy of Engineering in early February.
Harvard psychiatrist Jacqueline Olds offers some tips for coping with the snow and the dark days of winter.
Imaging study finds the first evidence of neuroinflammation in brains of chronic pain patients, which could lead to new, targeted treatments.
Framingham Heart Study, PNAS Early Edition, Harvard Medical School Investigators working to unravel the impact of genetics versus environment on traits such as obesity may also need to consider a new factor: when individuals were born.
Harvard will partner with Massachusetts General Hospital, Massachusetts Institute of Technology, and The Boston Globe for a new, weeklong festival of big ideas and bold solutions next October.
Harvard Stem Cell Institute researchers have taken what they describe as “the first step toward a pill that can replace the treadmill” for the control of obesity.
Harvard-affiliated researchers have found that a monthlong residential program could be better than standard-of-care outpatient programs in helping young adults stay drug-free.
Investigators at the Harvard-affiliated Massachusetts General Hospital have developed a system to accurately track the dynamic process of falling asleep, something that has not been possible with existing techniques.
Harvard Stem Cell Institute researchers at Massachusetts General and Boston Children’s hospitals for the first time have used a relatively new gene-editing technique to create what could prove to be an effective technique for blocking HIV from invading and destroying patients’ immune systems.
A small study from a group of Harvard-affiliated researchers at Massachusetts General Hospital investigates differences in how important brain structures are activated when women view images of their own children and their dogs.
Three nonprofits with strong Harvard ties have joined forces at the front lines of the Ebola epidemic in West Africa.
Harvard researchers working at the Broad Institute of MIT and Harvard have uncovered nine rare genetic mutations that dramatically increase the risk of developing type 2 diabetes. The discovery of the mutations highlights the dizzying genetic diversity of a disease rapidly spreading around the world.
A new device inspired by the human spleen and developed by a team at Harvard’s Wyss Institute for Biologically Inspired Engineering may radically transform the way doctors treat sepsis.
A Harvard Stem Cell Institute study comparing how blood stem cells and leukemia cells consume nutrients found that cancer cells are far less tolerant of shifts in their energy supply than their normal counterparts. The results suggest there could be ways to target and kill cancer cells without affecting healthy cells.
The protective gear needed to get Sierra Leone’s health clinics reopened, coupled with public education about the Ebola epidemic, are the greatest areas of need, according to a Harvard Fulbright Fellow and physician from Sierra Leone.
Studies begun by Harvard Stem Cell Institute scientists eight years ago have led to a report that may be a major step in developing treatments for amyotrophic lateral sclerosis, or Lou Gehrig’s disease.